Search Results - "Bernard Haendler"
-
1
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Published in International journal of molecular sciences (04-05-2018)“…Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate,…”
Get full text
Journal Article -
2
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
Published in International journal of molecular sciences (03-06-2022)“…Cancer arises following alterations at different cellular levels, including genetic and epigenetic modifications, transcription and translation dysregulation,…”
Get full text
Journal Article -
3
Targeting DNA Damage Response in Prostate and Breast Cancer
Published in International journal of molecular sciences (04-11-2020)“…Steroid hormone signaling induces vast gene expression programs which necessitate the local formation of transcription factories at regulatory regions and…”
Get full text
Journal Article -
4
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Published in Nature medicine (01-10-2018)“…Cancer cells rely on dysregulated gene expression. This establishes specific transcriptional addictions that may be therapeutically exploited. Yet, the…”
Get full text
Journal Article -
5
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Published in International journal of molecular sciences (24-01-2023)“…The reduction in androgen synthesis and the blockade of the androgen receptor (AR) function by chemical castration and AR signaling inhibitors represent the…”
Get full text
Journal Article -
6
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Published in International journal of molecular sciences (01-01-2024)“…The advent of targeted therapies has led to tremendous improvements in treatment options and their outcomes in the field of oncology. Yet, many cancers…”
Get full text
Journal Article -
7
Exploiting Epigenetic Alterations in Prostate Cancer
Published in International journal of molecular sciences (09-05-2017)“…Prostate cancer affects an increasing number of men worldwide and is a leading cause of cancer-associated deaths. Beside genetic mutations, many epigenetic…”
Get full text
Journal Article -
8
Dysregulated Transcriptional Control in Prostate Cancer
Published in International journal of molecular sciences (13-06-2019)“…Recent advances in whole-genome and transcriptome sequencing of prostate cancer at different stages indicate that a large number of mutations found in tumors…”
Get full text
Journal Article -
9
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
Published in Journal of medicinal chemistry (25-02-2016)“…TRIM24 is a transcriptional regulator as well as an E3 ubiquitin ligase. It is overexpressed in diverse tumors, and high expression levels have been linked to…”
Get full text
Journal Article -
10
Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation
Published in Molecular oncology (01-09-2020)“…Prostate cancer (PCa) is one of the most frequent tumor types in the male Western population. Early‐stage PCa and late‐stage PCa are dependent on androgen…”
Get full text
Journal Article -
11
Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents
Published in Cell death & disease (08-09-2016)“…Non-small cell lung cancer (NSCLC) has the highest incidence of cancer-related death worldwide and a high medical need for more effective therapies…”
Get full text
Journal Article -
12
Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs
Published in Expert opinion on therapeutic targets (02-07-2016)“…Histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) were the first epigenetic targets to be successfully addressed for cancer treatment, but more…”
Get more information
Journal Article -
13
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma
Published in British journal of haematology (01-09-2017)“…Summary The epigenome is often deregulated in cancer and treatment with inhibitors of bromodomain and extra‐terminal proteins, the readers of epigenetic…”
Get full text
Journal Article -
14
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
Published in International journal of molecular sciences (22-01-2023)“…Radium-223 dichloride and enzalutamide are indicated for metastatic castration-resistant prostate cancer and their combination is currently being investigated…”
Get full text
Journal Article -
15
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis
Published in Molecular oncology (01-03-2024)“…Prostate cancer is a frequent malignancy in older men and has a very high 5‐year survival rate if diagnosed early. The prognosis is much less promising if the…”
Get full text
Journal Article -
16
The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?
Published in BMC evolutionary biology (18-12-2008)“…Based on the observation of an increased number of paralogous genes in teleost fishes compared with other vertebrates and on the conserved synteny between…”
Get full text
Journal Article -
17
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
Published in Cellular oncology (Dordrecht) (01-06-2021)“…Purpose 5′ adenosine monophosphate-activated kinase (AMPK) is an essential regulator of cellular energy homeostasis and has been associated with different…”
Get full text
Journal Article -
18
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Published in Oncotarget (02-02-2016)“…Androgen receptor (AR) mutations arise in patients developing resistance to hormone deprivation therapies. Here we describe BAY 1024767, a thiohydantoin…”
Get full text
Journal Article -
19
The ubiquitin-specific protease USP10 modulates androgen receptor function
Published in Molecular and cellular endocrinology (21-12-2005)“…The role of the ubiquitin/proteasome system in degrading nuclear hormone receptors and regulating their transcriptional function has emerged in the last few…”
Get full text
Journal Article -
20
Stimulation of N-Terminal Truncated Isoform of Androgen Receptor Stabilizes Human Ether-á-go-go-Related Gene-Encoded Potassium Channel Protein via Activation of Extracellular Signal Regulated Kinase 1/2
Published in Endocrinology (Philadelphia) (01-10-2008)“…Proarrhythmic drugs induce long QT syndrome more frequently in women than men. The present study was designed to determine whether androgens regulate the…”
Get full text
Journal Article